Tuberostemonine produces antidepressant effects via the BDNF/TrkB/Erk/CREB signaling pathway.
Depression is a highly prevalent, debilitating psychiatric disorder that imposes severe global public health and socioeconomic burdens, greatly compromising patients' quality of life and social function. Current clinical antidepressants suffer from several critical drawbacks, including delayed therapeutic onset, limite...